Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 349481 - 349500 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 1 200 mg/600 mg | 15 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 200 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 1 200 mg/600 mg | 15 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 200 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 600 mg/600 mg | 10 ml, Hetteglass, Injeksjonsvæske, oppløsning, 600 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 600 mg/600 mg | 10 ml, Hetteglass, Injeksjonsvæske, oppløsning, 600 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 10 mg | 10 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 10 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AbacusMedicineA/S |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 1 x 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 1 x 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AbacusMedicineA/S |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XK01) olaparib | Lynparza 100 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB(2) |
| Norway | (L01XK01) olaparib | Lynparza 100 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AbacusMedicineA/S |
| Norway | (L01XK01) olaparib | Lynparza 100 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | OrifarmAS |
| Norway | (L01XK01) olaparib | Lynparza 150 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB(2) |
| Norway | (L01XK02) niraparib | Zejula 100 mg | 84 x 1 stk, Endoseblisterpakning, Kapsel, hard, 100 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms | GlaxoSmithKline(Ireland)Limited |
| Norway | (L01XK02) niraparib | Zejula 100 mg | 84 x 1 stk, Endoseblisterpakning, Kapsel, hard, 100 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms | OrifarmAS |
| Norway | (L01XK02) niraparib | Zejula 100 mg | 56 x 1 stk, Endoseblisterpakning, Kapsel, hard, 100 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms | OrifarmAS |
| Norway | (L01XK02) niraparib | Zejula 100 mg | 56 x 1 stk, Endoseblisterpakning, Kapsel, hard, 100 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms | GlaxoSmithKline(Ireland)Limited |
| Norway | (L01XK02) niraparib | Zejula 100 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Fallopian Tube Neoplasms;Peritoneal Neoplasms;Ovarian Neoplasms | GlaxoSmithKline(Ireland)Limited |
Pages
